↓ Skip to main content

Diagnóstico y tratamiento de la hipercolesterolemia familiar en España: documento de consenso

Overview of attention for article published in Atención Primaria (ScienceDirect), January 2015
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter
6 tweeters

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
69 Mendeley
Title
Diagnóstico y tratamiento de la hipercolesterolemia familiar en España: documento de consenso
Published in
Atención Primaria (ScienceDirect), January 2015
DOI 10.1016/j.aprim.2013.12.015
Pubmed ID
Authors

Pedro Mata, Rodrigo Alonso, Antonio Ruiz, Jose R. Gonzalez-Juanatey, Lina Badimón, Jose L. Díaz-Díaz, María Teresa Muñoz, Ovidio Muñiz, Enrique Galve, Luis Irigoyen, Francisco Fuentes-Jiménez, Jaime Dalmau, Francisco Pérez-Jiménez

Abstract

Familial hypercholesterolemia (FH) is a common genetic disorder, clinically manifested since birth, and associated with very high levels of plasma LDL-cholesterol (LDL-c), xanthomas, and premature coronary heart disease. Its early detection and treatment reduces coronary morbidity and mortality. Despite effective treatment being available, FH is under-diagnosed and under-treated. Identification of index cases and cascade screening using LDL-c levels and genetic testing are the most cost-effective strategies for detecting new cases and starting early treatment. Long-term treatment with statins has decreased the vascular risk to the levels of the general population. LDL-c targets are <130mg/dL for children and young adults, <100mg/dL for adults, and <70mg/dL for adults with known coronary heart disease or diabetes. Most patients do not to reach these goals, and combined treatments with ezetimibe or other drugs may be necessary. When the goals are not achieved with the maximum tolerated drug treatment, a reduction ≥50% in LDL-c levels can be acceptable. Lipoprotein apheresis can be useful in homozygous, and in treatment-resistant severe heterozygous, cases. This Consensus Paper gives recommendations on the diagnosis, screening, and treatment of FH in children and adults, and specific advice to specialists and general practitioners with the objective of improving the clinical management of these patients, in order to reduce the high burden of coronary heart disease.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
Mexico 1 1%
Spain 1 1%
Netherlands 1 1%
Unknown 65 94%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 14 20%
Student > Master 13 19%
Researcher 13 19%
Student > Doctoral Student 4 6%
Other 3 4%
Other 12 17%
Unknown 10 14%
Readers by discipline Count As %
Medicine and Dentistry 33 48%
Nursing and Health Professions 6 9%
Agricultural and Biological Sciences 5 7%
Social Sciences 3 4%
Biochemistry, Genetics and Molecular Biology 3 4%
Other 7 10%
Unknown 12 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 May 2020.
All research outputs
#5,680,783
of 17,648,139 outputs
Outputs from Atención Primaria (ScienceDirect)
#284
of 821 outputs
Outputs of similar age
#63,278
of 199,042 outputs
Outputs of similar age from Atención Primaria (ScienceDirect)
#6
of 13 outputs
Altmetric has tracked 17,648,139 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 821 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 199,042 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.